US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.70

-3.5908-0.20%

Number of Gainers:2

Number of Losers:17

Number of Flat:- -

PE:- -

High:1,844.83

Open:1,843.77

Low:1,825.88

Close:1,835.29

Volume:94.13M

Turnover:5.53B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

Moderna Stock (MRNA) Was the Best Performer in August

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization

China's Ascletis Pharma H1 Net Loss Widens on Higher R&D Costs

Aethlon Medical Says All Pre-Funded Warrants are Exercised

Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US

MT Newswires Live

NanoViricides provides updateon Measles Drug Treatment Program

NanoViricides Drafts Phase II Trial Protocol for NV-387 Measles Treatment

Abbott Launches the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at Similar Price to Its Existing Similac Powdered Formula

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial

MT Newswires Live

Analyst Warns of Significant Clinical and Regulatory Risks Facing Ibio Inc’s Drug Pipeline

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune

BioNTech SE Slides as Bold HIV Bet Takes Shape

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK4568/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1831.6982,"timestamp":1789070399999,"preClose":1835.2891,"halted":0,"volume":94127665,"delay":0,"changeRate":-0.001957,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-3.59082,"latestTime":"09-10 16:00:00 EDT","open":1843.7695,"high":1844.8345,"low":1825.875,"amount":5530296282.364558,"amplitude":0.010331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.81388,"peRate":46.873968,"turnoverRate":0.006785,"increases":2,"decrements":17,"flats":0,"marketCap":1489973728402,"floatMarketCap":1456164959030},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1844.8345,"amplitude":0.010331,"preClose":1835.2891,"low":1825.875,"pbRate":"4.81388","latestPrice":1831.6982,"volume":94127665,"delay":0,"open":1843.7695,"prevYearClose":1637.1339,"prevWeekClose":1896.2245,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1903.6779,"twentyDayClose":1769.2863,"sixtyDayClose":1652.1289,"secType":"PLATE","market":"US","turnoverRate":0.006785,"peRate":46.873968,"marketCap":1489973728402,"floatMarketCap":1456164959030,"timestamp":1789070399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":2,"down":17,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664200767","title":"Moderna Stock (MRNA) Was the Best Performer in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664200767","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664200767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:18","pubTimestamp":1788196728,"startTime":"0","endTime":"0","summary":"Moderna’s ($MRNA) stock rose 152% in August, making it the best-performing security during the month.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4501","BK4532","LGHT","BK4534","BK4568","BK4588","BK4139","MRNA","IDNA","BK4533","MRNX","BK4548","WDNA","GNOM","BK4551","BK4585","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002661","title":"AstraZeneca PLC Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002661?lang=en_us&edition=fundamental","pubTime":"2026-09-01 00:00","pubTimestamp":1788192000,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC advanced 0.3% to SEK1,563.50 Monday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.9% to 2,707.24.The stock's rise  snapped a three-day losing streak.The company closed SEK362.00 below its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 352,573, compared to the 50-day average trading volume of 546,664.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZNH","LU0058720904.USD","LU0432979614.USD","BK4568","AZN","LU2237443549.SGD","LU2237443895.HKD","LU1267930573.SGD","LU2237443465.HKD","LU0029864427.USD","LU2089984988.USD","LU2417539215.USD","BK4007","LU0109394709.USD","LU0708994859.HKD","LU1829250122.USD","LU2236285917.USD","LU2237443382.USD","LU2237443978.SGD","BK4585","BK4588","LU2468319806.SGD","LU2456880835.USD","LU0320765992.SGD","LU0289739699.SGD","LU0128525929.USD","LU0310800379.SGD","IE00B3T34201.USD","LU2462157665.USD","LU2237443622.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663515009","title":"Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization","url":"https://stock-news.laohu8.com/highlight/detail?id=2663515009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663515009?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:51","pubTimestamp":1788184315,"startTime":"0","endTime":"0","summary":"An announcement from Aethlon Medical ( ($AEMD) ) is now available. Aethlon Medical, Inc. reported that, following recent exercises of certain pre-f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-warrant-exercises-clarifying-capitalization?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-warrant-exercises-clarifying-capitalization?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEMD","BK4568","BK4082","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663966006","title":"China's Ascletis Pharma H1 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2663966006","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663966006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:31","pubTimestamp":1788183111,"startTime":"0","endTime":"0","summary":"China's Ascletis Pharma H1 net loss widens on higher R&D costsOverviewChina biopharma developer's interim net loss widened 263% yr/yr to RMB319.7 mlnTotal income for the period fell 49% yr/yrR&D expen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","01228","BK4551","BK1574","BK4535","BK4548","BNTX","BK1515","BK1161","BK4588","BK4139","01672","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663057430","title":"Aethlon Medical Says All Pre-Funded Warrants are Exercised","url":"https://stock-news.laohu8.com/highlight/detail?id=2663057430","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663057430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182150,"startTime":"0","endTime":"0","summary":"Aethlon Medical says all pre-funded warrants are exercisedAethlon Medical reported all previously outstanding pre-funded warrants were exercised following recent warrant exercises.Common shares outsta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLc5SWhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","AEMD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005353","title":"Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005353","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005353?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:56","pubTimestamp":1788180966,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  introduced Similac 360 Total Care Made With Whole Milk, a ready-to-feed liquid infant formula made with whole milk, in the US, the company said Monday.The company said the formula combines whole milk with an exclusive blend of five human milk oligosaccharides and is designed to support infants' immune systems, brain development and digestive health.The product is available at Target  and Amazon , with availability at Walmart  and other retailers expected in the coming weeks.Abbott added that the 8- and 32-fluid-ounce sizes will be priced similarly to powdered Similac 360 Total Care on a per-feeding basis and produced at its US facility.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2211815571.USD","SG9999002224.SGD","LU2324357040.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0070302665.USD","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4533","LU0320765489.SGD","LU2133065610.SGD","IE0002141913.USD","LU1691799644.USD","LU0122379950.USD","LU2089984988.USD","SGXZ41872573.SGD","BK4588","LU1914381329.SGD","PJP","IE00BJT1NW94.SGD","BK4566","LU0170899867.USD","LU0868494617.USD","SGXZ23171101.USD","LU0882574055.USD","LU1989763427.SGD","LU1989763690.USD","BK4592","LU2237957811.SGD","TMED","LU0432979614.USD","BK4082","LU1721429741.USD","LU1721429402.USD","LU1057294990.SGD","ABT","LU0266013472.USD","LU2237957902.USD","SG9999002232.USD","LU1670628061.USD","IHI","BK4568","LU0234572021.USD","LU1023059063.AUD","LU1670627923.USD","BK4585","LU0114720955.EUR","SG9999004303.SGD","LU0208291251.USD","BK4504","LU2112291526.USD","LU1061106388.HKD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663500530","title":"NanoViricides provides updateon Measles Drug Treatment Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2663500530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663500530?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:45","pubTimestamp":1788180332,"startTime":"0","endTime":"0","summary":"The company said, “While CDC is reviewing the two recent measles-related fatalities in Pennsylvania, the total number of confirmed measles cases in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-provides-updateon-measles-drug-treatment-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-provides-updateon-measles-drug-treatment-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDC","NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003610","title":"NanoViricides Drafts Phase II Trial Protocol for NV-387 Measles Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003610","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663003610?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:31","pubTimestamp":1788179503,"startTime":"0","endTime":"0","summary":"NanoViricides drafts Phase II trial protocol for NV-387 measles treatmentNanoViricides moved toward a Phase II trial of NV-387 to treat measles, with a draft protocol now in circulation.Clinical resul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL2RQYSm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008522","title":"Abbott Launches the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at Similar Price to Its Existing Similac Powdered Formula","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008522?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:00","pubTimestamp":1788177607,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUASQB8R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2211815571.USD","LU0058720904.USD","LU0114720955.EUR","BK4568","LU2089984988.USD","BK4082","LU2133065610.SGD","LU0234572021.USD","IE0002141913.USD","LU1989763427.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU1691799644.USD","LU0170899867.USD","LU0868494617.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1914381329.SGD","LU1989763690.USD","BK4592","LU1057294990.SGD","SG9999002224.SGD","IHI","BK4585","IE00B2B36J28.USD","TMED","LU0208291251.USD","LU1061106388.HKD","LU2324357040.USD","BK4588","SGXZ41872573.SGD","LU0320765489.SGD","LU0882574055.USD","IE0009355771.USD","PJP","SG9999004303.SGD","LU1670627923.USD","SG9999002232.USD","LU1023059063.AUD","LU1721429402.USD","BK4566","BK4504","ABT","LU0070302665.USD","LU0266013472.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU2237957902.USD","IE00BJT1NW94.SGD","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008638","title":"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008638?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:50","pubTimestamp":1788177029,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTX","BK4585","XBI","BK4588","PBE","BK4551","LU0128526141.USD","BK4581","LU0114720955.EUR","LU0109394709.USD","LU0029874061.USD","BK4139","LABU","LU0889565916.HKD","BK4137","BK4548","BK4535","LU0882574055.USD","LU0320765992.SGD","GNMX","ALNY","LKFT","BK4568","HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663781170","title":"Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663781170","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663781170?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:38","pubTimestamp":1788161936,"startTime":"0","endTime":"0","summary":"Hutchmed  said Monday its experimental combination of Orpathys and Tagrisso demonstrated a statistically significant improvement in progression-free survival in a China phase 3 trial involving certain patients with non-small cell lung cancer.The company said the combination also showed encouraging overall survival benefits compared with Tagrisso alone, which was a secondary endpoint of the trial.Orpathys is jointly developed by AstraZeneca  and Hutchmed and commercialized by AstraZeneca, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029864427.USD","BK4007","LU2237443895.HKD","LU2237443382.USD","LU0128525929.USD","LU2237443978.SGD","IE00B3T34201.USD","LU0432979614.USD","LU0310800379.SGD","LU2089984988.USD","BK4568","BK4531","LU0058720904.USD","LU2237443622.USD","LU2417539215.USD","LU2456880835.USD","LU2237443465.HKD","LU2237443549.SGD","BK4588","HCM","LU2236285917.USD","LU2462157665.USD","LU0889565916.HKD","LU2468319806.SGD","LU0109394709.USD","BK4585","AZN","LU0708994859.HKD","LU1829250122.USD","LU1267930573.SGD","LU0320765992.SGD","AZNH","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663273490","title":"Analyst Warns of Significant Clinical and Regulatory Risks Facing Ibio Inc’s Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2663273490","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663273490?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:07","pubTimestamp":1788156463,"startTime":"0","endTime":"0","summary":"Ibio Inc (IBIO) has disclosed a new risk, in the Innovation / R&D category. The analyst notes that Ibio Inc faces substantial risk because interim ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/analyst-warns-of-significant-clinical-and-regulatory-risks-facing-ibio-incs-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/analyst-warns-of-significant-clinical-and-regulatory-risks-facing-ibio-incs-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663446024","title":"CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663446024","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663446024?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:10","pubTimestamp":1788153044,"startTime":"0","endTime":"0","summary":"BUZZ-CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial** CanSino Biologics Hong Kong stock6185.HKleads slide in HK-listed shares of Chinese vaccine makers after news that BioNT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S04S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","06185","BK1574","BNTX","BK4568","BK4139","BK1515","BK4535","688185","BK1191","BK1161","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177566071","title":"August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566071","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177566071?lang=en_us&edition=fundamental","pubTime":"2026-08-30 13:40","pubTimestamp":1788068423,"startTime":"0","endTime":"0","summary":"August was expected to be a quiet month for markets, yet it has instead become a profound release of policy signals.US Treasury Secretary Scott Bessent has intervened in both the dollar-yen exchange...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","LU1035773651.USD","LU2092937148.SGD","IE0009G5SDU7.USD","IE00BKVL7J92.USD","LU1979441026.SGD","LU1974910355.USD","LU2347655156.SGD","LU2249611893.SGD","LU2954938101.SGD","LU1629891620.HKD","LU2213496289.HKD","BK4612","NVD2.UK","LU0965509010.AUD","LU1880398471.USD","LU0942090050.USD","LU2237957902.USD","ROM","SG9999001424.SGD","LU0310800379.SGD","LU1699723380.USD","FAI","LU1861215975.USD","LU1720051017.SGD","IE00BZ199S13.USD","LU2505996681.GBP","LU0494093205.USD","NVDD","BK4529","IE00B7KXQ091.USD","LU0203201768.USD","3NVD.UK","SG9999014567.USD","SG9999018865.SGD","LU1839511570.USD","SG9999015945.SGD","IE0034235295.USD","LU1721428933.USD","LU0553294199.USD","LU0308772762.SGD","LU1718418525.SGD","BK4543","DIPS","LU0158827781.USD","LU2430703178.SGD","LU0342679015.USD","BK4527","TRFK","LU0957808578.USD","NVDW","LU0353189680.USD","LU1066051225.USD","LU1084165304.USD","LU2420271590.USD","LU0390134368.USD","IE00BQXX3D17.EUR","LU2065170008.USD","LU2637965513.SGD","LU0672654240.SGD","LU1232071149.USD","LU1551013342.USD","LU1003077747.HKD","LU0861579265.USD","LU1934455277.USD","IE00B3S45H60.SGD","BK4588","LU2244417387.USD","LU1144417596.USD","LU0444971666.USD","LU1989764664.SGD","LU0069063385.USD","LU0323591593.USD","LU1116320737.USD","LU0094547139.USD","LU2237443978.SGD","LU1244550494.USD","IE00B19Z8X17.USD","SG9999017495.SGD","IE00BQXX3F31.USD","MRNA","IGV","LU1935042215.USD","IE00BFSS8Q28.SGD","SGXZ99366536.SGD","IE00B775SV38.USD","HK0000306685.HKD","IE00BJLML261.HKD","LU2237443382.USD","LU0109392836.USD","THMR","LU2491049909.HKD","IE0005OL40V9.USD","LU1571399168.USD","LU1066051811.HKD","LU0345768153.USD","LU1935043536.SGD","LU1261432733.SGD","LU1244550577.SGD","IE000KEQY171.SGD","LU1496350502.SGD","NVDG","IE000W1ABFV2.USD","LU2237438978.USD","LU0353189763.USD","SG9999004303.SGD","LU0823434740.USD","NVD3.UK","LU2264538146.SGD","SG9999015341.SGD","LU0795875169.SGD","LU0210528500.USD","LU0323239441.USD","GNOM","LU2133065610.SGD","LU0133085943.USD","LU1821325948.USD","LU2290526834.HKD","LU2242650005.HKD","HK0000914686.HKD","IE000YTNTUN2.SGD","LU1917777945.USD","BK4549","TEK","LU1988902786.USD","BK4598","LU1400636491.USD","LU0957791311.USD","LU2999663052.SGD","IE00BZ1G4Q59.USD","LU0444973449.USD","LU0868494708.USD","LU1670756490.USD","NVDU","LU1951198990.SGD","LU1645745479.HKD","LU0234572021.USD","LU2326559502.SGD","LU1064131342.USD","NVDS.UK","LU1935043023.USD","LU2065171402.SGD","LU0070217475.USD","LU0476273544.USD","IE00BJTD4V19.USD","LU1868837136.USD","BK4139","IE0004091025.USD","IE00BMPRXQ63.HKD","LU0276348264.USD","LU0056508442.USD","LU0724617625.USD","CNEQ","MRNY","LU0109391861.USD","LU1116320901.HKD","LU0234570918.USD","LU2413666426.HKD","ESLG","LU2471134796.USD","LU2860962120.EUR","LU1868837300.USD","IE00BKDWB100.SGD","LU0170899867.USD","LU2097344431.USD","LU0965508806.USD","BK4554","LU2361044949.HKD","LU0265550359.USD","IE00BK4W5L77.USD","LU0417517546.SGD","LU2294711713.HKD","LU1366333091.USD","IXN","LU2602419157.SGD","SG9999014559.SGD","SGXZ31699556.SGD","LU1732799900.SGD","LU0097036916.USD","LU1633808545.USD","SOXQ","LU0964807845.USD","BK4534","LU2271345857.HKD","LU0138981039.USD","LU2250418816.HKD","LU1267930730.SGD","LU1720051108.HKD","LU2360106780.USD","LU2089284900.SGD","LU1642822529.SGD","BK4568","LU0061474705.USD","LU2054465674.USD","LU0786609619.USD","LU2168564149.EUR","BK4532","IE00B1XK9C88.USD","IE00B3M56506.USD","LU2237443549.SGD","LU1923622614.USD","LU0943347566.SGD","LU0128525929.USD","IE00BQXX3C00.GBP","IE00BD6J9T35.USD","LU1791710582.SGD","SG9999015978.USD","LU1674673428.USD","LU0820562030.AUD","NVDY","LU2272731782.SGD","IE00BJJMRX11.SGD","LU0154236417.USD","LU0823421416.USD","LU0061474960.USD","LU0689472784.USD","LU2125154778.USD","LU0061475181.USD","LU1934455863.HKD","LU1435385759.SGD","NVC","IE000ITXATA3.USD","LU1923623000.USD","SG9999002232.USD","LU0187121727.USD","LU2322448791.USD","LU2458330243.SGD","LU0472753341.HKD","NVYY","LU2357125470.USD","NVD","IDNA","LU0708994859.HKD","LU0726765562.USD","LU2272731600.USD","LU2148611432.USD","TTXU","LU2750360997.AUD","LU3102509885.SGD","NVDO","LU1814569148.SGD","LU1989764748.USD","LU0174119429.USD","LU2125909916.SGD","SPTE","BK4141","LU0289960550.SGD","LU0345768740.USD","SG9999015358.SGD","GAMR","LU2491050071.SGD","SG9999014914.USD","07788","IE0009356076.USD","IE00BJJMRY28.SGD","LU0912757837.SGD","LU1983260115.SGD","LU2413666699.HKD","LU0127658192.USD","SG9999014898.SGD","LU2506951792.HKD","LU2247934214.USD","IE0034235188.USD","BK4579","LU0511384066.AUD","HK0000306701.USD","LU1548497426.USD","LU1244550221.USD","LU0256863811.USD","LU2357305700.SGD","IE000Q6AESB8.SGD","LU0225283273.USD","SG9999015952.SGD","BK4585","IE00BWXC8680.SGD","USXF","LU1316542783.SGD","LU0011850046.USD","HK0000320223.HKD","GB00BDT5M118.USD","SNPE","LU0795875086.SGD","LU1119994496.HKD","LU2403377893.USD","LU0348723411.USD","LU1400636657.SGD","SG9999002224.SGD","IE00BYXW3230.USD","LU0081259029.USD","LU2347655073.USD","SGXZ81514606.USD","LU1551013425.SGD","IE00BJTD4N35.SGD","SGXZ51526630.SGD","LU2077746001.SGD","LU1429558221.USD","LU2087625088.SGD","AIFD","NVII","HK0000819398.USD","SMH","LU2237443895.HKD","LU2272731865.HKD","LU0251132253.USD","LU2211815571.USD","LU2746668461.USD","LU0823434583.USD","LU1868836914.USD","IE00BMPRXR70.SGD","LGHT","IE00B19Z9505.USD","LU1951200564.SGD","LU1037948541.HKD","LU2100268510.USD","LU0080751232.USD","LU0882574139.USD","HK0000304805.HKD","LU0738911758.USD","LU0211327993.USD","LU2471134523.USD","LU0266013472.USD","ANV","LU0823414478.USD","LU0029864427.USD","BK4548","LU2125909759.SGD","LU2089985449.USD","LU0965509283.SGD","FTEC","LU0079474960.USD","LU0107464264.USD","VGT","LU0823414551.USD","IE00B3SWFQ91.USD","LU2265009873.SGD","CHPX","LU2756315664.SGD","NVIW.SI","LU2750360641.GBP","LU0274383776.USD","LU2236285917.USD","IE0001KFT4U8.USD","LU1267930573.SGD","LU2111349929.HKD","LU2433249047.HKD","IE00BDCRKT87.USD","LU1145028129.USD","ESUM","VT","LU2462591350.SGD","IE00B5TLWC47.USD","LU1861220033.SGD","LFGY","LU2097344357.USD","07388","LU0820561909.HKD","LU1803068979.SGD","2NVD.UK","IE0004445239.USD","AIPI","LU2931357623.SGD","LU2108987350.USD","LU0889565833.HKD","LU0175139822.USD","LU1623119135.USD","LU2462591277.SGD","LU2471134952.CNY","SG9999000418.SGD","NVDS","LU1732800096.USD","LU2125909247.SGD","LU1791710400.SGD","NVDL","JGRO","IE00B4JS1V06.HKD","LU0077335932.USD","EFIV","SG9999014906.USD","LU0006306889.USD","IE00B5949003.HKD","BK4550","LU0354030438.USD","LU2452424414.USD","LU2360032135.SGD","LU0979878070.USD","LU1066053197.SGD","LU1280957306.USD","LU0215105999.USD","ABFL","LU0466842654.USD","LU0345770308.USD","LU1804176565.USD","LU0289961442.SGD","LU0683600562.USD","LU1712237335.SGD","LU2063271972.USD","LU0528227936.USD","SOXY","TTEQ","WDNA","BK4567","LU2361045086.USD","BK4608","LU1868836591.USD","LU1153585028.USD","LU2286300806.USD","IE00B4YYXB79.USD","LU2023251221.USD","BK4592","ILDR","LU2028103732.USD","LU1691799644.USD","LU2023250330.USD","LU0267386448.USD","SGXZ23171101.USD","NVDB","LU1868836757.USD","LU2361044865.SGD","LU2065169927.USD","IE00BFSS7M15.SGD","LU1069344957.HKD","NVDQ","LU2746668974.SGD","LU0642271901.SGD","IE00BK4W5M84.HKD","LU0708995401.HKD","AGOX","SG9999015986.USD","LU0310799852.SGD","LU1496350171.SGD","IE0004445015.USD","LU0203202063.USD","LU1989772840.SGD","LU1242518931.SGD","LU2461242641.AUD","LU2191332357.HKD","IE0003U64NQ7.SGD","LU2087621335.USD","LU2430703251.USD","LU2491050154.USD","LU2360107168.USD","LU0823421333.USD","LU0557290698.USD","IE00BMPRXN33.USD","LU2322448957.HKD","LU0265550946.USD","LU2083900584.USD","IE00B775H168.HKD","LU2417539215.USD","TYLG","LU0689626769.HKD","LU0082616367.USD","BK4587","LU1935042991.SGD","LU2279689827.SGD","BK4503","WISE","LU0157215616.USD","LU0395794307.EUR","LU0788109477.HKD","LU1069347547.HKD","LU1992135399.USD","LU0661504455.SGD","LU1674673691.USD","LU2456880835.USD","LU0210536198.USD","SG9999014542.SGD","SOXX","LU1366192091.USD","BK4533","HK0000914660.USD","LU2471134879.HKD","HK0000320264.USD","FDTX","LU0545039389.USD","LU0719512351.SGD","LU1934455194.USD","IE0034235303.USD","LU2023250504.SGD","LU0124676726.USD","SNVD.UK","LU1815336760.USD","MRNX","CLSE","LU1852331112.SGD","LU1935042488.USD","LU1914381329.SGD","LU2092627202.USD","BK4605","LU0210533765.USD","LU0158827948.USD","LU0198837287.USD","LU2065171311.SGD","LU2168564222.USD","LU0096364046.USD","LU2089283258.USD","LU2463028550.USD","LU0965509101.SGD","LU2242649171.HKD","LU1267930490.SGD","LU1242518857.USD","LU0320765059.SGD","BK4581","LU2237443465.HKD","LU2487616109.SGD","LU2552382058.USD","CMAG","LU0345769631.USD","IE00BN29S564.USD","LU0354030511.USD","LU0985320562.USD","LU1923622291.USD","LU2462157665.USD","LU2896262040.SGD","IE00B19Z8W00.USD","HK0000532082.HKD","SMHX","SG9999014575.USD","LU2237443622.USD","LU1400636574.HKD","SGXZ80539844.SGD","NVDA","LU2458330169.SGD","IE00BHPRN162.USD","BK4614","LU1992135472.HKD","LU0640476718.USD","SG9999018857.SGD","LU2756315318.SGD","BK4551","LU1861127337.USD","LU2106854487.HKD","LU2168563687.JPY","LU1815333072.USD","LU2047632596.USD","LU1323610961.USD","LU2473716301.USD","LU1066051498.USD","LU1037948897.HKD","SNVDAmain","LU0868494617.USD","LU0143551892.USD","BK4501","LU2237957811.SGD","LU1035775433.USD","LU0238689110.USD","LU2168564065.EUR","NULC","LU0072462426.USD","LU2168564495.EUR","LU0048584097.USD","LU0057025933.USD","LU2543165471.USD","IE00BDRTCR15.USD","LU0289739343.SGD","LU2381873111.SGD","NVDX","LU0096362180.USD","LU0345769128.USD","IE00B1BXHZ80.USD","LU0345770993.USD","LU1989772923.USD","SHOC","LU0256863902.USD","HK0000304797.USD","XLK","USD","IE0004086264.USD","IETC","LU1778281490.HKD","LU0323240290.USD","LU1880398554.USD","LU2430703095.HKD","LU0316494557.USD","LU0347712357.USD","LU2505996509.AUD","LU2552382215.SGD","SG9999014880.SGD","LU0787776722.HKD","IE00BKPKM429.USD","LU2125909593.SGD","LU2394011477.USD","LU0106261372.USD","LU2125154935.USD","LU0949170772.SGD","LU1202635105.USD","LU0053666078.USD","LU1127390331.HKD","LU0211328371.USD","LU2552382132.HKD","METV","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","TBXU","SG9999015945.SGD","BK4588","BK4578","LU0234570918.USD","LU1066053197.SGD","BK4532","LU1061106388.HKD","LU1585245621.USD","LU0965508806.USD","LU0882574055.USD","BK4568","LU0965509010.AUD","LU2112291526.USD","LU0823416689.USD","BIB","IE00BKVL7J92.USD","BK4566","LU1934455863.HKD","LU1934455277.USD","LU2324357040.USD","TMED","GILD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0114720955.EUR","BK4550","LU1430594728.SGD","IE00B3T34201.USD","IBB","LU1571399168.USD","LU1934455194.USD","SG9999015978.USD","BMED","IBBQ","BBH","LU0122379950.USD","LU0965509283.SGD","MEDI","BK4583","BK4139","LU0058720904.USD","LU1023059063.AUD","LU1839511570.USD","LU0289739699.SGD","LU2089984988.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017218","title":"Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017218","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017218?lang=en_us&edition=fundamental","pubTime":"2026-08-29 23:03","pubTimestamp":1788015782,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer is quietly reshaping its pipeli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-pivots-new-trials-target-obesity-cancer-autoimmune?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-pivots-new-trials-target-obesity-cancer-autoimmune?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","LU0321505868.SGD","LU1066051498.USD","LU0306807586.USD","LU1023059063.AUD","LU0456855351.SGD","PFE","BK4599","LU2596442595.SGD","LU1883839398.USD","LU0170899867.USD","BK4533","LU0225771236.USD","SG9999013999.USD","BK4550","BK4585","SG9999002224.SGD","SG9999001176.SGD","LU0225284248.USD","OZEM","SG9999011175.SGD","LU0985481810.HKD","BK4534","SG9999002232.USD","IE00B3T34201.USD","SG9999003800.SGD","BK4588","BK4568","BK4592","LU1057294990.SGD","LU1894683264.USD","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4581","IE000M9KFDE8.USD","SG9999001176.USD","LU0058720904.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU1066053197.SGD","LU0321505439.SGD","LU1894683348.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU0868494617.USD","LU0234572021.USD","SGXZ57979304.SGD","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017172","title":"BioNTech SE Slides as Bold HIV Bet Takes Shape","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017172?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:01","pubTimestamp":1788012111,"startTime":"0","endTime":"0","summary":"BioNTech SE ( ($BNTX) ) has fallen by -9.52%. Read on to learn why. BioNTech SE shares fell 9.52% over the past week, even as the company signaled ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/biontech-se-slides-as-bold-hiv-bet-takes-shape?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/biontech-se-slides-as-bold-hiv-bet-takes-shape?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4585","BNTX","BK4139","BK4535","BK4588","BK4551","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017647","title":"Abbott, Vistra, Unity, United, Nu: Insider Shockwave","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017647?lang=en_us&edition=fundamental","pubTime":"2026-08-29 21:01","pubTimestamp":1788008465,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($ABT)), (($VST)), (($U)), (($UAL)) and (($NU)). Here is a breakdown of their recent trades and their v...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/abbott-vistra-unity-united-nu-insider-shockwave?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/abbott-vistra-unity-united-nu-insider-shockwave?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999004303.SGD","LU0208291251.USD","LU1721429741.USD","TMED","PJP","UAL","BK4500","LU2211815571.USD","LU1721429402.USD","LU0882574055.USD","ABT","LU0170899867.USD","BK4533","BK4585","BK4008","IE00B4R5TH58.HKD","UBCP","JETS","IE00BJT1NW94.SGD","LU2089984988.USD","LU2237957811.SGD","IE0002141913.USD","LU2324357040.USD","LU2133065610.SGD","IYT","SG9999002232.USD","BK4211","LU1989763690.USD","BK4588","BK4568","BK4592","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0122379950.USD","UNTY","XTN","LU0289739699.SGD","BK4581","LU0432979614.USD","LU0058720904.USD","IE00B2B36J28.USD","LU2468319806.SGD","SGXZ41872573.SGD","BK4082","IE0009355771.USD","LU0320765489.SGD","LU0114720955.EUR","LU0868494617.USD","LU0234572021.USD","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019778","title":"Pharma Industry Stares Down Biggest Patent Cliff in Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019778?lang=en_us&edition=fundamental","pubTime":"2026-08-29 09:00","pubTimestamp":1787965200,"startTime":"0","endTime":"0","summary":"Most companies sell a hit product for as long as customers want it. For drugmakers, a clock starts before a drug is even approved: Patents run out, lower-priced copycats flood in and sales collapse. B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","LU0266013472.USD","LU2461242641.AUD","RXL","LU1934455194.USD","LU1323610961.USD","IE0002270589.USD","IE0009354923.USD","LU0256863902.USD","LU2023251221.USD","BK4532","AGNG","SG9999013999.USD","LU0211331839.USD","LU0882574139.USD","OZEM","NVOH","LU0354030511.USD","LU0868494617.USD","LU1934455863.HKD","LU0553294199.USD","SG9999001176.SGD","LU1145028129.USD","SG9999015341.SGD","LU2361044865.SGD","LU0238689110.USD","SGXZ51526630.SGD","LU2347655073.USD","LU2237443549.SGD","VHT","SG9999014567.USD","BK4139","LU2360106947.USD","IE000MB6IJN5.SGD","LLY","LU1430594728.SGD","IE00B2B36J28.USD","LU0708994859.HKD","LU2596442595.SGD","LU2265009873.SGD","LU0029864427.USD","LU0345770308.USD","LU0353189680.USD","SGXZ81514606.USD","LU0203347892.USD","LU2468319806.SGD","LU2087625088.SGD","LU0289961442.SGD","SG9999014542.SGD","NVO","LU1814569148.SGD","LU0225283273.USD","IE00BK4W5L77.USD","LU2125909593.SGD","SG9999002232.USD","SG9999014575.USD","SG9999014898.SGD","BK4548","LU2433249047.HKD","LU2357627491.SGD","IE00BJJMRY28.SGD","LU1979441026.SGD","MRNA","LU0114720955.EUR","SG9999002224.SGD","LU2357305700.SGD","LU0820561909.HKD","LU1868836591.USD","BK4501","LU0310799852.SGD","LU1720051108.HKD","LU2347655156.SGD","IHE","LU2242652126.USD","LU2129689431.USD","LU2168564495.EUR","LU2491049909.HKD","LU2491050154.USD","MEDX","LU0385154629.USD","LU1093756168.USD","LU1291159041.SGD","IE00BJJMRX11.SGD","LU2237443622.USD","PTH","SG9999015945.SGD","LU2125154935.USD","BK4566","IE0000B7K699.USD","IE00B42XCP33.USD","LU0122379950.USD","LU0321505868.SGD","LU0861579265.USD","IE0005OL40V9.USD","FHLC","LU0395794307.EUR","LU2756315318.SGD","LU0323591593.USD","LU1496350171.SGD","IE00BFXG1179.USD","LU1551013425.SGD","LU0174119429.USD","IE000M9KFDE8.USD","LU2471134952.CNY","LU2108987350.USD","LU1670711123.USD","LU0109394709.USD","LU2237443382.USD","LU1162221912.USD","LU1548497426.USD","LU1868836757.USD","IE00BJLML261.HKD","BK4516","SG9999015952.SGD","LU1244550577.SGD","LU1280957306.USD","LU1670711040.USD","BK4550","LU1941712264.USD","IE0001KFT4U8.USD","HRTS","LU0980610538.SGD","MHIP","ELIL","LU0310800379.SGD","SG9999015978.USD","SG9999015986.USD","LU1232071149.USD","LU0061475181.USD","LU1244550221.USD","LLYX","IYH","LU0466842654.USD","LU0477156953.USD","LU0234572021.USD","LU2063271972.USD","LU2237443978.SGD","LU2125154778.USD","LU1032466523.USD","LU1551013342.USD","LU1267930490.SGD","IDNA","SG9999014906.USD","GLAM","LU0203345920.USD","LU2237443895.HKD","BBH","IE0002141913.USD","LU1236620834.HKD","LU0786609619.USD","LU0109391861.USD","LU1267930730.SGD","LU0965509010.AUD","LU0672654240.SGD","LU1093756325.SGD","IE00B19Z3581.USD","BK4559","TRUH","LU2456880835.USD","LU2896262040.SGD","LU0130517989.USD","LU0316494557.USD","IE0004445015.USD","LU1670628061.USD","GDOC","LU0306806265.USD","SGXZ99366536.SGD","IE00B3PB1722.GBP","LU0882574055.USD","LU0069063385.USD","IE00B775H168.HKD","IE00BFTCPJ56.SGD","LU2168564149.EUR","CURE","LU1868837136.USD","LU0211327993.USD","SG9999017495.SGD","BK4568","LU2106854487.HKD","LU2271345857.HKD","LU2237443465.HKD","BK4588","LU0256863811.USD","LU1917777945.USD","LU0211328371.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0640476718.USD","IE000F7OJYX1.SGD","MRK","MRNY","SG9999018857.SGD","IE00BLSP4239.USD","LU0070302665.USD","LU2552382215.SGD","SG9999018865.SGD","LU0237698245.USD","LU0859254822.USD","LU2236285917.USD","LU1983299246.USD","LU2242646821.SGD","LU0345770993.USD","IE00BK4W5M84.HKD","LU1069344957.HKD","LU1623119135.USD","LU1267930573.SGD","LU1074936037.SGD","SG9999014914.USD","PAWZ","IE00BKDWB100.SGD","LU1883839398.USD","IE0009355771.USD","ELIS","LU0942090050.USD","LU2129689605.HKD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU2213496289.HKD","LU0203202063.USD","IE00BFSS8Q28.SGD","LU2552382132.HKD","LU0820562030.AUD","LU0472753341.HKD","LU0320765646.SGD","LU2602419157.SGD","LU1804176565.USD","LU0321505439.SGD","SGXZ31699556.SGD","IE000BZT7R73.USD","LU2087621335.USD","IXJ","SGXZ57979304.SGD","BMED","LU0320765489.SGD","LU1720051017.SGD","LU0289739343.SGD","LU1691799644.USD","LU1732799900.SGD","LU2361045086.USD","LU1244550494.USD","LU0943347566.SGD","LLII","LU1066053197.SGD","IE000SO60NU8.SGD","LU0306807586.USD","SG9999003800.SGD","LU0096364046.USD","LU2750360641.GBP","LGHT","LU1261432733.SGD","LU1989772840.SGD","LU0158827948.USD","SG9999014880.SGD","MEDI","IE00B1XK9C88.USD","LU0265550946.USD","LU0820561818.USD","LU0456855351.SGD","LU1929549753.HKD","IE00BWXC8680.SGD","LU1496350502.SGD","LU2360032135.SGD","LU1585245621.USD","LU1069347547.HKD","LU1934455277.USD","LU0708995401.HKD","LU0545039389.USD","SG9999001440.SGD","LU0289739699.SGD","LU1974910355.USD","LU0511384066.AUD","LU1718418525.SGD","IE00BBT3K403.USD","LU2133065610.SGD","SG9999011175.SGD","LU0683600562.USD","LU2264538146.SGD","LU0353189763.USD","LU1732800096.USD","NVOC","BK4534","IE00BJT1NW94.SGD","THNR","LU2750360997.AUD","LU2089984988.USD","LU0949170772.SGD","LU0471298777.SGD","LU2023250330.USD","LU0648001328.SGD","IE000WAW04H5.SGD","LU2417539215.USD","LU1035775433.USD","LU1037948541.HKD","LU0417517546.SGD","LU2168564222.USD","LU1066051811.HKD","LU0225284248.USD","LU1023059063.AUD","BK4533","LU0823434740.USD","LU0106261372.USD","FTXH","LU0154236417.USD","LU2491050071.SGD","LU0471298694.HKD","LU0320765992.SGD","LU0689472784.USD","LU2471134523.USD","LU0098860793.USD","BK4007","IE00BN29S564.USD","IE00B4R5TH58.HKD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU0203201768.USD","LU0823416689.USD","TMED","LU0868494708.USD","LU0964807845.USD","IE00B4JS1V06.HKD","LU2211815571.USD","LU0985481810.HKD","NVOX","LU2168563687.JPY","LU0124676726.USD","LU1670710588.SGD","LU2462591350.SGD","LU2168564065.EUR","LU1670710661.SGD","LU0208291251.USD","LU0965509101.SGD","LU0354030438.USD","LU1670627923.USD","LU0170899867.USD","LU1923622614.USD","MRNX","WDNA","GNOM","LU2089284900.SGD","PPH","LU1839511570.USD","IE00BKPKM429.USD","IE00BKVL7J92.USD","LU2089283258.USD","LU2361044949.HKD","IE00B19Z3B42.SGD","BK4551","LU1116320901.HKD","LU2471134879.HKD","LU0985320562.USD","LU1035773651.USD","LU0795875086.SGD","LU0158827781.USD","LU0689626769.HKD","LU1116320737.USD","IE00BFSS7M15.SGD","LU0097036916.USD","LU2028103732.USD","LU0058720904.USD","LLYZ","LU0787776722.HKD","LU2746668974.SGD","LU0006306889.USD","LU0965508806.USD","BK4581","LU0738911758.USD","LU2111349929.HKD","LU0726765562.USD","SG9999014559.SGD","LU1201861249.SGD","LU0225771236.USD","LU1941712348.USD","LU1699723380.USD","LU1989772923.USD","LU0267386448.USD","IE00B7KXQ091.USD","LU1003077747.HKD","LU0889565916.HKD","LU0210536198.USD","LU1066051225.USD","BK4599","LU1366192091.USD","JDOC","LU2023250843.SGD","RVMD","LU1712237335.SGD","LU0823434583.USD","LU2023250504.SGD","LU0432979614.USD","LU0320765059.SGD","LU1236620750.USD","IE00BVYPNV92.GBP","LU2552382058.USD","LU2471134796.USD","LU0795875169.SGD","SG9999001176.USD","IE0004445239.USD","BK4585","LU1989771016.USD","LU0912757837.SGD","ABBV","LU2112291526.USD","IE00BVYPNW00.USD","LU1127390331.HKD","LU1868837300.USD","BMY","LU1057294990.SGD","LU1037948897.HKD","LU2324357040.USD","LU0265550359.USD","LU0128525929.USD","LU2129689514.USD","CANC","IE00BN8TJ469.HKD","LU0057025933.USD","LU1064131342.USD","LU0133085943.USD","XLV","LU2125909247.SGD","LU0198837287.USD","IE00BGHQF631.EUR","LU2746668461.USD","IE00BLSP4452.SGD","LU1571399168.USD","LU1988902786.USD","LU0965509283.SGD","LU0079474960.USD","LU1629891620.HKD","LU0094547139.USD","PJP","LU1868836914.USD","LU2756315664.SGD","SG9999015358.SGD","ILDR","LU2462157665.USD","LU0234570918.USD","IE00BSNM7G36.USD","GB00BDT5M118.USD","LU1066051498.USD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663201015","title":"Novavax Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2663201015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663201015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:27","pubTimestamp":1787952420,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  advanced 2.32% to $9.26 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.52% to 26,402.42 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.The stock's rise snapped a two-day losing streak.Novavax Inc. closed 22.64% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Merck & Co. Inc.  fell 0.80% to $148.35.Trading volume  eclipsed its 50-day average volume of 4.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4547","BK4585","NVAX","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":9,"totalSize":220,"code":"91000000","status":"200"}]}}